. Author manuscript; available in PMC: 2007 Dec 21.

Published in final edited form as: Clin Cancer Res. 2006 Apr 15;12(8):2526–2537. doi: 10.1158/1078-0432.CCR-05-2061

Table 3.

Mixed clinical response in patient 42

Tumor site	Tumor area (cm²)^*
	Pretreatment (7/20/01)	After course 1 (11/27/01)	After course 2 (3/22/02)
Thyroid gland	3.3	0	0
Adrenal gland	4.0	0	0
Kidney	6.8	0	0
Lymph node 1	14.4	0	0
Lymph node 2	10.3	0	0
S.c.1	5.0	0	0
S.c. 2	4.0	0	0
S.c. 3	0	1.4	0
Gall bladder	0.3	1.1	1.5
Total	48.1	2.5	1.5

NOTE: Patient 42 was treated with vaccines and high-dose IL-2 on Arm 3 of the randomized trial.

Bidimensional measurements obtained from computed tomography scans. Numerous additional s.c. lesions assessable only by physical exam regressed partially or completely during treatment.